Moderna, Inc. Common Stock
$154.04
-$4.03 (-2.55%)
$150.26Day Range$159.79
Key Statistics
Market Cap
$61.50B
Shares Outstanding
399.2M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Dec 7, 2018
Round Lot
100
Locale
US
Trading Data
Day Open
$158.35
Day High
$159.79
Day Low
$150.26
Volume
20.24M
VWAP
$154.63
Prev Close
$158.07
Transactions
--
Acc. Volume
--
About Moderna, Inc. Common Stock
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)SIC 28364,700 employees325 BINNEY STREET, CAMBRIDGE, MA, 02142(617) 714-6500IPO Dec 7, 2018US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001682852
- Composite FIGI
- BBG003PHHZT1
- Share Class FIGI
- BBG003PHHZV8
- Ticker Root
- MRNA
- SIC Code
- 2836
About Moderna, Inc. Common Stock (MRNA) Stock
Moderna, Inc. Common Stock (MRNA) closed the 2026-09-18 session at $154.04, down 2.55% versus the previous close (-4.03). The stock opened at $158.35 and traded between $150.26 and $159.79 during that session. Session trading volume was 20.2M shares. The volume-weighted average price (VWAP) is $154.63.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Moderna, Inc. Common Stock has a market capitalization of $61.50 billion. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. MRNA is listed on the XNAS exchange. The company employs approximately 4,700 people. Moderna, Inc. Common Stock is headquartered in CAMBRIDGE, MA. The recorded listing date is 2018-12-07.
On this page you can find market MRNA stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.